Dr. Reddys Labs (RDY) Reports Q4 EPS of Rs14.52

Dr. Reddys Labs (NYSE: RDY) reported Q4 EPS of Rs14.52. Revenue for the quarter came in at Rs87.27 billion.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

You May Also Be Interested In

• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
• JPMorgan Downgrades Li Ning Co. Ltd. (2331:HK) (LNNGF) to Neutral
• GE Vernova T&D India (GVTD:IN) PT Raised to INR5,300 at Emkay Global